Phonak Audeo R Infinio 90 vs RxEars Rxi

The Phonak Audeo R Infinio 90 is a premium prescription behind-the-ear hearing aid released in 2024, priced at $4,996. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #18 among 39 prescription hearing aids tested. Speech clarity is a standout strength in our testing. Speech in quiet scored 4.4/5, a strong result that sits 1.01 points above the category average. Speech in noise performance is more mixed at 2.5/5—above the category average by 0.37 points, but only moderate in absolute terms. This pattern suggests the Infinio 90 excels in calmer listening environments while offering incremental benefits in challenging noise. Streaming music quality impressed at 4.0/5, a strong score that lands 1.24 points above category average. Feedback handling scored 4.2/5, which is strong in absolute terms though 0.52 points below the category average. Own-voice comfort was mixed at 2.2/5, falling 0.50 points below average—something to discuss with your hearing care provider if natural voice quality is a priority. The Infinio 90 competes in a crowded premium segment. At this price point, alternatives like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieved higher overall scores in our testing. Buyers seeking Phonak's ecosystem and strong speech-in-quiet performance may find the Infinio 90 appealing, though those prioritizing noise performance or own-voice comfort should compare options carefully with their provider.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.